EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring Current Molecular Targets in the Treatment of Neovascular Age-Related Macular Degeneration toward the Perspective of Long-Term Agents

Serena Fragiotta, Lorena Bassis, Barmak Abdolrahimzadeh, Alessandra Marino, Massimiliano Sepe, Solmaz Abdolrahimzadeh iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25084433 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Serena Fragiotta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurosciences, Mental Health, and Sense Organs (NESMOS) Department, Faculty of Medicine and Psychology, University of Rome Sapienza, 00189 Rome, Ital…. Hauptthemen laut MEDLINE: Macular Degeneration, Angiogenesis Inhibitors, Molecular Targeted Therapy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-lasting anti-vascular endothelial growth factor (anti-VEGF) agents have become an option to reduce treatment frequency, with ongoing research exploring optimal responses and safety profiles. This review delves into molecular targets, pharmacological aspects, and strategies for achieving effective and enduring disease control in neovascular age-related macular degeneration (AMD). The molecular pathways involved in macular neovascularization, including angiogenesis and arteriogenesis, are explored. VEGF, PlGF, Ang-1, and Ang-2 play crucial roles in regulating angiogenesis, influencing vessel growth, maturation, and stability. The complex interplay of these factors, along with growth factors like TGFβ and bFGF, contributes to the pathogenesis of neovascular membranes. Current anti-VEGF therapies, including bevacizumab, ranibizumab, aflibercept, brolucizumab, and faricimab, are discussed with a focus on their pharmacokinetics and clinical applications. Strategies to achieve sustained disease control in AMD involve smaller molecules, increased drug dosages, and novel formulations. This narrative review provides a comprehensive overview of the molecular targets and pharmacological aspects of neovascular AMD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationAngiogenesis InhibitorsMolecular Targeted TherapyHumansVascular Endothelial Growth Factor AAnimalsNeovascularization, Pathologic

Stichwörter der Autor:innen

afliberceptage-related macular degeneration (AMD)anti-vascular endothelial growth factor (anti-VEGF)brolucizumabfaricimab

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Neurosciences, Mental Health, and Sense Organs (NESMOS) Department, Faculty of Medicine and Psychology, University of Rome Sapienza, 00189 Rome, Italy.
  • UOC Ophthalmology, Department of Surgical Areas, S.M. Goretti Hospital, 04100 Latina, Italy.
  • North West Ophthalmology, Practiceplus Hospital, Rochdale OL16 2UP, Manchester, UK.
  • St. Andrea Hospital, Via di Grottarossa 1035/1039, 00189 Rome, Italy.

ORCID-Profile: Solmaz Abdolrahimzadeh

Zitieren

APA

Fragiotta, S., Bassis, L., Abdolrahimzadeh, B., Marino, A., Sepe, M., & Abdolrahimzadeh, S. (2024). Exploring Current Molecular Targets in the Treatment of Neovascular Age-Related Macular Degeneration toward the Perspective of Long-Term Agents. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084433

Vancouver

Fragiotta S, Bassis L, Abdolrahimzadeh B, Marino A, Sepe M, Abdolrahimzadeh S. Exploring Current Molecular Targets in the Treatment of Neovascular Age-Related Macular Degeneration toward the Perspective of Long-Term Agents. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084433

BibTeX
@article{Fragiotta2024,
  author = {Fragiotta, Serena and Bassis, Lorena and Abdolrahimzadeh, Barmak and Marino, Alessandra and Sepe, Massimiliano and Abdolrahimzadeh, Solmaz},
  title = {Exploring Current Molecular Targets in the Treatment of Neovascular Age-Related Macular Degeneration toward the Perspective of Long-Term Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25084433}
}
Kostenlos starten →